Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study
Abstract Background Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis, primarily due to failed early detection. HCC screening is recommended among individuals with cirrhosis using biannual abdominal ultrasound, for earlier tumor detection, administration of cura...
Main Authors: | Jörn Lewin, Denise Kottwitz, Johanna Aoyama, Theo deVos, Jorge Garces, Oliver Hasinger, Stefanie Kasielke, Florian Knaust, Preeti Rathi, Sebastian Rausch, Gunter Weiss, Alexander Zipprich, Edward Mena, Tse-Ling Fong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-021-01714-8 |
Similar Items
-
The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
by: M. Chris Runken, et al.
Published: (2019-07-01) -
A nationwide population-based prospective study of cirrhosis in Iceland
by: Sigurdur Olafsson, et al.
Published: (2021-06-01) -
Liver cirrhosis and pregnancy
by: Claudio Tiribelli, et al.
Published: (2006-07-01) -
Pain treatment in patients with cirrhosis
by: Jordi Gras-Ozimek, et al.
Published: (2022-07-01) -
Changing role of laparoscopy in the management of patients with cirrhosis
by: Adisa A, et al.
Published: (2008-01-01)